Crescita Therapeutics (TSE:CTX) Trading 57% Higher – What’s Next?

Crescita Therapeutics Inc. (TSE:CTX)’s stock price traded up 57% during trading on Monday . The company traded as high as C$0.74 and last traded at C$0.73. 639,938 shares changed hands during mid-day trading, an increase of 1,454% from the average session volume of 41,177 shares. The stock had previously closed at C$0.47.

Crescita Therapeutics Price Performance

The company has a current ratio of 3.12, a quick ratio of 2.29 and a debt-to-equity ratio of 2.98. The company has a market capitalization of C$13.96 million, a P/E ratio of 37.50 and a beta of -0.39. The business’s fifty day moving average price is C$0.49 and its 200-day moving average price is C$0.47.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.